IL13 and Alzheimer disease: It has been showed that ILC2 in AD skin exhibits an elusive immunophenotype, and that among all the ILCs, inducible T-cell costimulatory (ICOS)-expressing cells, comprising both ILC2 and ILC3, are the main producer of IL-13 in the dermis (23).